AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist

0.072
0.0000.00%

20min DelayMarket Closed Jul 23 11:45 AET

5.41MMarket Cap-699P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

Cost of revenue

Gross profit

Operating expense

111.69%8.98M

73.65%4.24M

-28.33%2.44M

3.41M

Selling and administrative expenses

42.86%1.29M

-9.36%900.39K

-28.58%993.39K

--1.39M

-General and administrative expense

42.86%1.29M

-9.36%900.39K

-28.58%993.39K

--1.39M

Research and development costs

149.80%7.4M

160.05%2.96M

-12.38%1.14M

--1.3M

Other operating expenses

-22.75%292.53K

22.13%378.7K

-56.74%310.08K

--716.85K

Operating profit

-111.69%-8.98M

-73.65%-4.24M

28.33%-2.44M

-3.41M

Net non-operating interest income (expenses)

897.84%797.08K

-49.69%79.88K

-4.17%158.79K

165.7K

Non-operating interest income

897.84%797.08K

-49.69%79.88K

-4.17%158.79K

--165.7K

Other net income (expenses)

107.20%432.35K

208.66K

-117.95K

Special income (charges)

----

---117.95K

-Less:Impairment of capital assets

----

--117.95K

Other non-operating income (expenses)

107.20%432.35K

--208.66K

----

Income before tax

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Income tax

Earnings from equity interest net of tax

Net income

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Net income continuous operations

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

---3.36M

Noncontrolling interests

Net income attributable to the company

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Diluted earnings per share

-96.01%-0.1031

-73.03%-0.0526

49.16%-0.0304

-0.0598

Basic earnings per share

-96.01%-0.1031

-73.03%-0.0526

49.16%-0.0304

-0.0598

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue
Cost of revenue
Gross profit
Operating expense	111.69%8.98M	73.65%4.24M	-28.33%2.44M	3.41M
Selling and administrative expenses	42.86%1.29M	-9.36%900.39K	-28.58%993.39K	--1.39M
-General and administrative expense	42.86%1.29M	-9.36%900.39K	-28.58%993.39K	--1.39M
Research and development costs	149.80%7.4M	160.05%2.96M	-12.38%1.14M	--1.3M
Other operating expenses	-22.75%292.53K	22.13%378.7K	-56.74%310.08K	--716.85K
Operating profit	-111.69%-8.98M	-73.65%-4.24M	28.33%-2.44M	-3.41M
Net non-operating interest income (expenses)	897.84%797.08K	-49.69%79.88K	-4.17%158.79K	165.7K
Non-operating interest income	897.84%797.08K	-49.69%79.88K	-4.17%158.79K	--165.7K
Other net income (expenses)	107.20%432.35K	208.66K		-117.95K
Special income (charges)	----	----	----	---117.95K
-Less:Impairment of capital assets	----	----	----	--117.95K
Other non-operating income (expenses)	107.20%432.35K	--208.66K	----	----
Income before tax	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Income tax	0	0	0	0
Earnings from equity interest net of tax
Net income	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Net income continuous operations	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	---3.36M
Noncontrolling interests
Net income attributable to the company	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Diluted earnings per share	-96.01%-0.1031	-73.03%-0.0526	49.16%-0.0304	-0.0598
Basic earnings per share	-96.01%-0.1031	-73.03%-0.0526	49.16%-0.0304	-0.0598
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall